1 ML atropine sulfate 0.4 MG/ML Injection

RxCUI
1666781
RxNorm name
1 ML atropine sulfate 0.4 MG/ML Injection
Display name
Atropine (Injectable)
Full name
1 ML atropine sulfate 0.4 MG/ML Injection
Term type
SCD
Status
Active
Strength
0.4 mg/ml
Dose form
Injection 1 ml
Route
Injectable
Updated
2026-10-20 20:51:48

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102015
Active start
102015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
atropine sulfate0.4 MG / 1 MLatropineatropine sulfate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
atropine1223

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0404-9802-010404-9802Atropine Sulfate Atropine SulfateHenry Schein, IncANDA216120
0517-1004-250517-1004Atropine Sulfate ATROPINE SULFATEAmerican Regent, Inc.ANDA216120
0641-6274-250641-6274Atropine Sulfate Atropine SulfateHikma Pharmaceuticals USA Inc.ANDA217345
51662-1627-351662-1627Atropine sulfate Atropine sulfateHF Acquisition Co LLC, DBA HealthFirstANDA216120
70069-631-2570069-631Atropine Sulfate Atropine SulfateSomerset Therapeutics, LLCANDA215969
71872-7312-171872-7312Atropine Sulfate ATROPINE SULFATEMedical Purchasing Solutions, LLCANDA216120
71872-7341-171872-7341Atropine Sulfate Atropine SulfateMedical Purchasing Solutions, LLCANDA215969
84549-631-2584549-631Atropine Sulfate Atropine SulfateProPharma DistributionANDA215969

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2161200404-9802Atropine Sulfate Atropine SulfateANDAHenry Schein, Inc
ANDA2173450641-6274Atropine Sulfate Atropine SulfateANDAHikma Pharmaceuticals USA Inc.
ANDA21596970069-631Atropine Sulfate Atropine SulfateANDASomerset Therapeutics, LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 28 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00404980201rxnav_ndcsyes
00517040125rxnav_ndcsyes
00517100401rxnav_ndcsyes
00517100425rxnav_ndcsyes
00641627401rxnav_ndcsyes
00641627425rxnav_ndcsyes
16729052508rxnav_ndcsyes
16729052563rxnav_ndcsyes
51662162701rxnav_ndcsyes
51662162702rxnav_ndcsyes
51662162703rxnav_ndcsyes
70069063101rxnav_ndcsyes
70069063125rxnav_ndcsyes
71872724601rxnav_ndcsyes
71872731201rxnav_ndcsyes
71872734101rxnav_ndcsyes
84549063125rxnav_ndcsyes
00404982001rxnav_historical
00404998801rxnav_historical
10019025012rxnav_historical
10019025039rxnav_historical
16729052503rxnav_historical
51662133901rxnav_historical
52584040125rxnav_historical
54868074002rxnav_historical
55154571505rxnav_historical
55154571508rxnav_historical
71872700101rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Atropine SulfateATROPINE SULFATEHenry Schein, Incb753894e-81f8-4e81-b07a-c338311ded5b2025-10-27Warnings, Adverse reactionsExact identifier
ndc (package): 0404-9802-01
ndc (product): 0404-9802
ndc11 (package): 00404980201
rxcui: 1666781
Atropine SulfateATROPINE SULFATEHikma Pharmaceuticals USA Inc.a66eecf9-2d8b-4e2d-8a05-d718dcbc35422025-10-08Warnings, Adverse reactionsExact identifier
ndc (package): 0641-6274-25
ndc (product): 0641-6274
ndc11 (package): 00641627425
ndc11 (package): 00641627401
rxcui: 1666781
Atropine SulfateATROPINE SULFATEMedical Purchasing Solutions, LLC3fa81939-4495-28d5-e063-6394a90a1f2d2025-09-25Warnings, Adverse reactionsExact identifier
ndc (package): 71872-7341-1
ndc (product): 71872-7341
ndc11 (package): 71872734101
rxcui: 1666781
Atropine SulfateATROPINE SULFATEProPharma Distribution3eef6300-9c78-82b2-e063-6294a90a54992025-09-16Warnings, Adverse reactionsExact identifier
ndc (package): 84549-631-25
ndc (product): 84549-631
ndc11 (package): 84549063125
rxcui: 1666781
Atropine SulfateATROPINE SULFATESomerset Therapeutics, LLCa6fac578-c7bc-4b3c-a454-7889cc8191182024-07-04Warnings, Adverse reactionsExact identifier
ndc (package): 70069-631-25
ndc (product): 70069-631
ndc11 (package): 70069063125
ndc11 (package): 70069063101
rxcui: 1666781
Atropine sulfateATROPINE SULFATEHF Acquisition Co LLC, DBA HealthFirst007728fc-f4cb-d519-e063-6394a90ae0332024-01-22Warnings, Adverse reactionsExact identifier
ndc (package): 51662-1627-3
ndc (product): 51662-1627
ndc11 (package): 51662162702
ndc11 (package): 51662162701
ndc11 (package): 51662162703
rxcui: 1666781
Atropine SulfateATROPINE SULFATEMedical Purchasing Solutions, LLC09d086f2-db9a-5e15-e063-6394a90abe182023-11-10Warnings, Adverse reactionsExact identifier
ndc (package): 71872-7312-1
ndc (product): 71872-7312
ndc11 (package): 71872731201
rxcui: 1666781
Atropine SulfateATROPINE SULFATEAmerican Regent, Inc.6fee1727-52b7-4f73-ab45-ef47d6a1c5bb2021-09-01Warnings, Adverse reactionsExact identifier
ndc (package): 0517-1004-25
ndc (product): 0517-1004
ndc11 (package): 00517100425
ndc11 (package): 00517100401
rxcui: 1666781

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6fee1727-52b7-4f73-ab45-ef47d6a1c5bbatropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]38These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 196020210901
a66eecf9-2d8b-4e2d-8a05-d718dcbc3542atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]34These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 196020251008
007728fc-f4cb-d519-e063-6394a90ae033atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]34ATROPINE SULFATE INJECTION USP 0.4mg/mL20240122
7d8fc6fd-1eb5-30b6-e053-2a91aa0aa9f0atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]34ATROPINE SULFATE INJECTION, USP 0.4mg/mL 1mL VIAL20221209
a6fac578-c7bc-4b3c-a454-7889cc819118atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]33These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 196020240704
b753894e-81f8-4e81-b07a-c338311ded5batropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]32These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION . ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 196020251027
bfc93de4-f731-31fa-e053-2a95a90aadcbatropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]32These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 196020230427
3fa81939-4495-28d5-e063-6394a90a1f2datropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]31These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 196020250925
3eef6300-9c78-82b2-e063-6294a90a5499atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]31These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 196020250916
09d086f2-db9a-5e15-e063-6394a90abe18atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY]31These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 196020231110

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
b753894e-81f8-4e81-b07a-c338311ded5bThese highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION . ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960Henry Schein, Inc20251027
d5e07279-48ca-4f83-9633-299e65a7f821These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960Accord Healthcare Inc. | Intas Pharmaceuticals Limited20251020
a66eecf9-2d8b-4e2d-8a05-d718dcbc3542These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960Hikma Pharmaceuticals USA Inc.20251008
3fa81939-4495-28d5-e063-6394a90a1f2dThese highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960Medical Purchasing Solutions, LLC20250925
3eef6300-9c78-82b2-e063-6294a90a5499These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960ProPharma Distribution20250916
d5e07279-48ca-4f83-9633-299e65a7f821These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960Accord Healthcare Inc. | Intas Pharmaceuticals Limited20250228
2eb646c5-8f92-4762-9217-f0a8b6173b4fThese highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION.ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960Henry Schein, Inc.20241014
b753894e-81f8-4e81-b07a-c338311ded5bThese highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION . ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960Henry Schein, Inc20240822
a6fac578-c7bc-4b3c-a454-7889cc819118These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960Somerset Therapeutics, LLC | Somerset Therapeutics Limited20240704
007728fc-f4cb-d519-e063-6394a90ae033ATROPINE SULFATE INJECTION USP 0.4mg/mLHF Acquisition Co LLC, DBA HealthFirst20240122
09d086f2-db9a-5e15-e063-6394a90abe18These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960Medical Purchasing Solutions, LLC20231110
78e42769-061f-4973-ac3a-dc3fcc4bf641ATROPINE SULFATE INJECTION, USPAmerican Regent, Inc.20230824
6ba4d3c9-44ce-97f6-e053-2a91aa0a2f88ATROPINE SULFATE INJECTION, USPMedical Purchasing Solutions, LLC20230605
bfc93de4-f731-31fa-e053-2a95a90aadcbThese highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960Medical Purchasing Solutions, LLC20230427
f87f7e0b-8ad1-406a-95de-883f831eed7dAtropine Sulfate 0.4 mg/mL Injection, USP 1 mL Single Dose VialHenry Schein, Inc.20221230
350dcd54-857d-4a65-9fd0-ad54f090fd7bAtropine Sulfate 0.4 mg/mL Injection, USP 1 mL Single Dose VialGeneral Injectables & Vaccines, Inc20221209
7d8fc6fd-1eb5-30b6-e053-2a91aa0aa9f0ATROPINE SULFATE INJECTION, USP 0.4mg/mL 1mL VIALHF Acquisition Co LLC, DBA HealthFirst20221209
6fee1727-52b7-4f73-ab45-ef47d6a1c5bbThese highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960American Regent, Inc.20210901
22b968d0-d806-4104-93fc-fc6b49bd4dd8National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01FAAnticholinergicsATC1-4atropine
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4atropine
FDASPLN0000175574AnticholinergicEPChas_epcatropine
FDASPLN0000175700Cholinergic Muscarinic AntagonistEPChas_epcatropine
FDASPLN0000175370Cholinergic AntagonistsMOAhas_moaatropine
FDASPLN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine
MEDRTD001285AtropineCHEMhas_ingredientatropine
MEDRTD001285AtropineCHEMhas_ingredientatropine sulfate
MEDRTD001249AsthmaDISEASEci_withatropine
MEDRTD001249AsthmaDISEASEci_withatropine sulfate
MEDRTD001919BradycardiaDISEASEmay_treatatropine
MEDRTD001919BradycardiaDISEASEmay_treatatropine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withatropine
MEDRTD003093Colitis, UlcerativeDISEASEci_withatropine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withatropine
MEDRTD004342Drug HypersensitivityDISEASEci_withatropine sulfate
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatatropine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatatropine sulfate
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withatropine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withatropine sulfate
MEDRTD006323Heart ArrestDISEASEmay_treatatropine
MEDRTD006323Heart ArrestDISEASEmay_treatatropine sulfate
MEDRTD006327Heart BlockDISEASEci_withatropine sulfate
MEDRTD006327Heart BlockDISEASEci_withatropine
MEDRTD007415Intestinal ObstructionDISEASEci_withatropine
MEDRTD007415Intestinal ObstructionDISEASEci_withatropine sulfate
MEDRTD007499Iris DiseasesDISEASEci_withatropine
MEDRTD007499Iris DiseasesDISEASEci_withatropine sulfate
MEDRTD007674Kidney DiseasesDISEASEci_withatropine sulfate
MEDRTD007674Kidney DiseasesDISEASEci_withatropine
MEDRTD007905Lens DiseasesDISEASEci_withatropine sulfate
MEDRTD007905Lens DiseasesDISEASEci_withatropine
MEDRTD008107Liver DiseasesDISEASEci_withatropine sulfate
MEDRTD008107Liver DiseasesDISEASEci_withatropine
MEDRTD008532Megacolon, ToxicDISEASEci_withatropine sulfate
MEDRTD008532Megacolon, ToxicDISEASEci_withatropine
MEDRTD009157Myasthenia GravisDISEASEci_withatropine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withatropine
MEDRTD015878MydriasisDISEASEinducesatropine
MEDRTD015878MydriasisDISEASEinducesatropine sulfate
MEDRTD011041PoisoningDISEASEmay_treatatropine sulfate
MEDRTD011041PoisoningDISEASEmay_treatatropine
MEDRTD012848Sinoatrial BlockDISEASEmay_treatatropine sulfate
MEDRTD012848Sinoatrial BlockDISEASEmay_treatatropine
MEDRTD013276Stomach UlcerDISEASEmay_treatatropine sulfate
MEDRTD013276Stomach UlcerDISEASEmay_treatatropine
MEDRTD013610TachycardiaDISEASEci_withatropine sulfate
MEDRTD013610TachycardiaDISEASEci_withatropine
MEDRTD013971ThyrotoxicosisDISEASEci_withatropine
MEDRTD013971ThyrotoxicosisDISEASEci_withatropine sulfate
MEDRTD000267Tissue AdhesionsDISEASEci_withatropine
MEDRTD000267Tissue AdhesionsDISEASEci_withatropine sulfate
MEDRTD014517Ureteral ObstructionDISEASEci_withatropine
MEDRTD014517Ureteral ObstructionDISEASEci_withatropine sulfate
MEDRTD014605UveitisDISEASEmay_treatatropine
MEDRTD014605UveitisDISEASEmay_treatatropine sulfate
MEDRTD014987XerostomiaDISEASEinducesatropine sulfate
MEDRTD014987XerostomiaDISEASEinducesatropine
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moaatropine sulfate
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_peatropine
MEDRTN0000008779Decreased Parasympathetic Acetylcholine ActivityPEhas_peatropine sulfate
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_peatropine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_peatropine sulfate
MEDRTN0000009808Positive ChronotropyPEhas_peatropine
MEDRTN0000009808Positive ChronotropyPEhas_peatropine sulfate
MEDRTN0000009820Pupillary DilationPEhas_peatropine
MEDRTN0000009820Pupillary DilationPEhas_peatropine sulfate
MEDRTN0000009842Salivation InhibitionPEhas_peatropine sulfate
MEDRTN0000009842Salivation InhibitionPEhas_peatropine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.4 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY1 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA215969
CODESANDAANDA216120
CODESANDAANDA217345
CODESNDANDA214652
CODESVUID4000625
NAMESPrescribable Synonymatropine sulfate 0.4 MG in 1 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File